Greenlight Capital Re reported third-quarter net profit of $3.2 million and a 90.5% combined ratio, generating $14.6 million in underwriting income. Fully diluted book value per share rose 0.8% to $20.78; innovations gross written premium grew 46%, and year-to-date share repurchases reached 5.4%.
GLRE · Greenlight Capital Re, Ltd.
4 customers — 70.5% of revenue (2025)
“For the Open Market segment, our four largest brokers each accounted for more than 10% of our gross written premiums, and in the aggregate, they accounted for approximately 70.5% of the segment's gross premiums written in 2025.”
6 customers — 53.6% of revenue (2025)
“For the Innovations segment, we had six customers that accounted for 53.6% of the segment's gross premiums written in 2025.”
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Price & Indicators
Key stats
- Close
- $16.25
- Open
- $16.37
- Day range
- $16.18–16.41
- 52-week closing range
- $12.60–19.00
- Average volume, 30 days
- 110K
- Short interest
- 692K · 2.1% of shares · 7.3 days
- Short volume, last session
- 34%
- Last earnings
- Nov 3, 2026
- Latest filing
- 10-Q · Nov 2
- Price history
- Jan 2020 to Nov 2026
Up next
Latest documents
Greenlight Capital Re reported net income of $3.2 million for Q3 2026, versus a $4.4 million net loss a year earlier. The improvement came mainly from lower net investment losses, partly offset by lower underwriting income.
Greenlight Capital Re reported third-quarter net income of $3.2 million, or $0.10 per diluted share, and a 90.5% combined ratio. It also agreed to repurchase 33% of its open-market buybacks from a trust tied to Chairman David Einhorn.
Metrics snapshot
Useful current figures from the complete screener profile.
Quarterly results
* Q4 derived as the full year minus Q1 to Q3.
AI Brief
Q2 FY26 earnings call · Aug 5, 2026TL;DR. Greenlight Re reported a Q2 2026 net loss of $29.6 million driven by $23.8 million in investment losses from Solasglas and a $25 million Middle East conflict reserve build (plus a $6.5M Qatar fire loss), while the Innovations segment posted a strong 89.7% combined ratio and received approval in principle to convert Syndicate 3456 to a full Lloyd's syndicate effective January 1, 2027.
- + Innovations gross written premiums grew 12% to $30.9M with net earned premiums up 16%
- + Received approval in principle from Lloyd's to convert Syndicate 3456 to a full syndicate effective January 1, 2027
- + Q2 investment losses essentially reversed in July with Solasglas returning +4.9% in July and YTD of +6.1%
- + Attritional loss ratio improved 4.3 points to 51.7% with prior year reserve development benefit of 1.4 points
- − Q2 investment loss of $23.8M driven by Solasglas return of -5.4% (longs +12%, shorts -12.3%, macro -5.4%)
- − Combined ratio deteriorated to 100.1% from 95.0% with cat/large losses at 17.1 points vs. 4% prior year
- − Fully diluted book value per share decreased 3.7% QoQ to $20.61 from $21.40 at March 31, 2026
- − Net written premium declined 11% in Q2 as company reduced net exposure in response to softening market
AI-generated from the earnings call and 8-K · may contain errors · not investment advice
Equibles Rating
blended score · not investment adviceBlended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders BuyIllustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from written earnings releases and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| 2026 YTD Returns (through June) | 1.1% | 2026 YTD (through June) | — |
| Combined ratio | 98.1% | six months ended June 30, 2026 | — |
| Combined ratio (Innovations segment) | 89.7% | Q2 2026 | — |
| Fully diluted book value per share non-GAAP | $20.61 | the second quarter 2026 (as of June 30, 2026) | — |
| Gross Premiums Written | 411.1M | 1H 2026 | — |
| Gross premiums written (Innovations segment) | $31M | Q2 2026 | — |
| Gross premiums written (Open Market segment) | $152M | Q2 2026 | — |
| Ordinary shares repurchased | 803,364 | the second quarter of 2026 | — |
| Prior year reserve development ratio | 7.2% | the three months ended June 30, 2026 filing | — |
| Return (Loss) on Equity | -4.1% | Q2 2026 | — |
| Total share repurchases | $14.2M | the three months ended June 30, 2026 filing | — |
| Underwriting expense ratio | 3.4% | the three months ended June 30, 2026 filing | — |
| Underwriting expenses ratio | 5.2% | the three months ended June 30, 2026 filing | — |
Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period
Versus peers
Insurance - Reinsurance — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
GLRE
this stock
Greenlight Capital Re, Ltd.
|
$523.90M | +11.5% | +4.8% | 9.6 | 2.1% |
|
RGA
Reinsurance Group Of America Inc
|
$17.27B | +31.7% | +7.2% | 10.3 | 1.5% |
|
EG
Everest Group, Ltd.
|
$15.63B | +24.3% | +1.2% | 8.9 | 4.1% |
|
RNR
Renaissancere Holdings Ltd
|
$13.89B | +22.3% | +9.9% | 5.7 | 2.9% |
|
SPNT
SiriusPoint Ltd
|
$3.02B | +20.0% | +23.1% | 6.5 | 4.6% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every section- Filed
- Nov 2, 2026
- This year
- 14
Greenlight Capital Re reported third-quarter net income of $3.2 million, or $0.10 per diluted share, and a 90.5% combined ratio. It also agreed to repurchase 33% of its open-market buybacks from a trust tied to Chairman David Einhorn.
ViewPerformance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| GLRE | -0.7% | +6.2% | +6.9% | +10.9% | +11.5% |
| SPY | -5.5% | -6.3% | -5.6% | -5.3% | +5.0% |
| vs SPY | +4.8% | +12.5% | +12.5% | +16.1% | +6.5% |
Capital returns
Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.